| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.23 | 0.004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |